highly significantp < 0.001
The follow-up period averaged 30.64 ± 11.66 weeks in the success group and 41.25 ± 26.72 weeks in the failure group, a difference that was highly significant ( p < 0.001).
The follow-up period averaged 30.64 ± 11.66 weeks in the success group and 41.25 ± 26.72 weeks in the failure group, a difference that was highly significant ( p < 0.001).